Ludlow J B, Davies-Ludlow L E, Brooks S L
Department of Diagnostic Sciences and General Dentistry, University of North Carolina School of Dentistry, Chapel Hill, North Carolina 27599, USA.
Dentomaxillofac Radiol. 2003 Jul;32(4):229-34. doi: 10.1259/dmfr/26310390.
This study provides effective dose measurements for two extraoral direct digital imaging devices, the NewTom 9000 cone beam CT (CBCT) unit and the Orthophos Plus DS panoramic unit.
Thermoluminescent dosemeters were placed at 20 sites throughout the layers of the head and neck of a tissue-equivalent RANDO phantom. Variations in phantom orientation and beam collimation were used to create three different CBCT examination techniques: a combined maxillary and mandibular scan (Max/Man), a maxillary scan and a mandibular scan. Ten exposures for each technique were used to ensure a reliable measure of radiation from the dosemeters. Average tissue-absorbed dose, weighted equivalent dose and effective dose were calculated for each major anatomical site. Effective doses of individual organs were summed with salivary gland exposures (E(SAL)) and without salivary gland exposures (E(ICRP60)) to calculate two measures of whole-body effective dose.
The effective doses for CBCT were: Max/Man scan, E(ICRP60)=36.3 micro Sv, E(SAL)=77.9 micro Sv; maxillary scan, E(ICRP60)=19.9 micro Sv, E(SAL)=41.5 micro Sv; and mandibular scan, E(ICRP60)=34.7 micro Sv, E(SAL)=74.7 micro Sv. Effective doses for the panoramic examination were E(ICRP60)=6.2 micro Sv and E(SAL)=22.0 micro Sv.
When viewed in the context of potential diagnostic yield, the E(ICRP60) of 36.3 micro Sv for the NewTom compares favourably with published effective doses for conventional CT (314 micro Sv) and film tomography (2-9 micro Sv per image). CBCT examinations resulted in doses that were 3-7 (E(ICRP60)) and 2-4 (E(SAL)) times the panoramic doses observed in this study.
本研究为两种口外直接数字化成像设备,即NewTom 9000锥形束CT(CBCT)设备和Orthophos Plus DS全景设备,提供有效剂量测量。
将热释光剂量计放置在组织等效RANDO体模头颈部各层的20个位置。通过改变体模方向和束准直,创建三种不同的CBCT检查技术:上颌和下颌联合扫描(Max/Man)、上颌扫描和下颌扫描。每种技术进行10次曝光,以确保从剂量计获得可靠的辐射测量值。计算每个主要解剖部位的平均组织吸收剂量、加权当量剂量和有效剂量。将各个器官的有效剂量与唾液腺照射剂量(E(SAL))相加以及不与唾液腺照射剂量(E(ICRP60))相加,以计算两种全身有效剂量测量值。
CBCT的有效剂量为:Max/Man扫描,E(ICRP60)=36.3微希沃特,E(SAL)=77.9微希沃特;上颌扫描,E(ICRP60)=19.9微希沃特,E(SAL)=41.5微希沃特;下颌扫描,E(ICRP60)=34.7微希沃特,E(SAL)=74.7微希沃特。全景检查的有效剂量为E(ICRP60)=6.2微希沃特和E(SAL)=22.0微希沃特。
从潜在诊断收益的角度来看,NewTom的E(ICRP60)为36.3微希沃特,与已公布的传统CT有效剂量(314微希沃特)和胶片断层摄影有效剂量(每张图像2 - 9微希沃特)相比具有优势。CBCT检查产生的剂量是本研究中观察到的全景剂量的3 - 7倍(E(ICRP60))和2 - 4倍(E(SAL))。